Acceptance of COVID-19 Vaccination During the COVID-19 Pandemic in China

Overview

Journal Vaccines (Basel)

Date 2020 Sep 2

PMID 32867224

Citations 512

Authors

Jiahao Wang

Rize Jing

Xiaozhen Lai

Haijun Zhang

Yun Lyu

Maria Deloria Knoll

Hai Fang

Affiliations

Soon will be listed here.

Abstract

Background: Faced with the coronavirus disease 2019 (COVID-19) pandemic, the development of COVID-19 vaccines has been progressing at an unprecedented rate. This study aimed to evaluate the acceptance of COVID-19 vaccination in China and give suggestions for vaccination strategies and immunization programs accordingly.

Methods: In March 2020, an anonymous cross-sectional survey was conducted online among Chinese adults. The questionnaire collected socio-demographic characteristics, risk perception, the impact of COVID-19, attitudes, acceptance and attribute preferences of vaccines against COVID-19 during the pandemic. Multivariate logistic regression was performed to identify the influencing factors of vaccination acceptance.

Results: Of the 2058 participants surveyed, 1879 (91.3%) stated that they would accept COVID-19 vaccination after the vaccine becomes available, among whom 980 (52.2%) wanted to get vaccinated as soon as possible, while others (47.8%) would delay the vaccination until the vaccine's safety was confirmed. Participants preferred a routine immunization schedule (49.4%) to emergency vaccination (9.0%) or either of them (41.6%). Logistic regression showed that being male, being married, perceiving a high risk of infection, being vaccinated against influenza in the past season, believing in the efficacy of COVID-19 vaccination or valuing doctor's recommendations could increase the probability of accepting COVID-19 vaccination as soon as possible, while having confirmed or suspected cases in local areas, valuing vaccination convenience or vaccine price in decision-making could hinder participants from immediate vaccination.

Conclusion: During the pandemic period, a strong demand for and high acceptance of COVID-19 vaccination has been shown among the Chinese population, while concerns about vaccine safety may hinder the promotion of vaccine uptake. To expand vaccination coverage, immunization programs should be designed to remove barriers in terms of vaccine price and vaccination convenience, and health education and communication from authoritative sources are important ways to alleviate public concerns about vaccine safety.

Citing Articles

Communicating COVID-19 vaccine information to Chinese communities in the UK: a qualitative study of their knowledge, information sources and trust.

Gong Q, Gao Z, Somerville I, Steele C, Wang D, Zhou H BMJ Public Health. 2025; 2(2):e000658.

PMID: 40018533 PMC: 11816719. DOI: 10.1136/bmjph-2023-000658.

Factors influencing COVID-19 vaccine acceptability among household heads in northern Nigeria: a community-based cross-sectional study.

Ahmad S, Aliyu H, Usman R, Abubakar A, Maijawa M, Suleiman B BMJ Open. 2025; 15(1):e083470.

PMID: 39788760 PMC: 11883584. DOI: 10.1136/bmjopen-2023-083470.

COVID-19 Pandemic and its Impact on Vaccine Hesitancy: A Review.

Widyaningsih S, Hakim M Oman Med J. 2024; 39(4):e646.

PMID: 39717459 PMC: 11664204. DOI: 10.5001/omj.2024.103.

Can social media promote vaccination? Strategies and effectiveness of COVID-19 vaccine popularization on Chinese Weibo.

Xu J, Guo D, Wu J, Xu J Front Public Health. 2024; 12:1436632.

PMID: 39697295 PMC: 11653587. DOI: 10.3389/fpubh.2024.1436632.

Acceptance-Hesitancy of COVID-19 Vaccination and Factors Affecting It in Adults: Systematic Review Study.

Darbandi A, Koupaei M, Kiani P, Ghanavati R, Najafi P, Hosseini J Immun Inflamm Dis. 2024; 12(11):e70076.

PMID: 39570098 PMC: 11580281. DOI: 10.1002/iid3.70076.

References

Raude J, Caille-Brillet A, Setbon M . The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?. PLoS Curr. 2010; 2:RRN1188. PMC: 2957695. DOI: 10.1371/currents.RRN1188. View

Tian H, Liu Y, Li Y, Wu C, Chen B, Kraemer M . An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020; 368(6491):638-642. PMC: 7164389. DOI: 10.1126/science.abb6105. View

Leung K, Wu J, Liu D, Leung G . First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet. 2020; 395(10233):1382-1393. PMC: 7195331. DOI: 10.1016/S0140-6736(20)30746-7. View

Kwok K, Lai F, Wei W, Wong S, Tang J . Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020; 80(6):e32-e33. PMC: 7151357. DOI: 10.1016/j.jinf.2020.03.027. View

Irwin K, Jalloh M, Corker J, Alpha Mahmoud B, Robinson S, Li W . Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey. Vaccine. 2017; 35(49 Pt B):6915-6923. DOI: 10.1016/j.vaccine.2017.06.026. View

Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti J . Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?. PLoS One. 2010; 5(4):e10199. PMC: 2856629. DOI: 10.1371/journal.pone.0010199. View

Bone A, Guthmann J, Nicolau J, Levy-Bruhl D . Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine. 2010; 28(51):8157-61. DOI: 10.1016/j.vaccine.2010.09.096. View

Ughasoro M, Esangbedo D, Tagbo B, Mejeha I . Acceptability and Willingness-to-Pay for a Hypothetical Ebola Virus Vaccine in Nigeria. PLoS Negl Trop Dis. 2015; 9(6):e0003838. PMC: 4467844. DOI: 10.1371/journal.pntd.0003838. View

Determann D, Korfage I, Lambooij M, Bliemer M, Richardus J, Steyerberg E . Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment. PLoS One. 2014; 9(7):e102505. PMC: 4109921. DOI: 10.1371/journal.pone.0102505. View

10.

Lurie N, Saville M, Hatchett R, Halton J . Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020; 382(21):1969-1973. DOI: 10.1056/NEJMp2005630. View

11.

Lau J, Yeung N, Choi K, Cheng M, Tsui H, Griffiths S . Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine. 2010; 28(29):4632-7. PMC: 7131323. DOI: 10.1016/j.vaccine.2010.04.076. View

12.

Seale H, Heywood A, McLaws M, Ward K, Lowbridge C, Van D . Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010; 10:99. PMC: 2864274. DOI: 10.1186/1471-2334-10-99. View

13.

Sypsa V, Livanios T, Psichogiou M, Malliori M, Tsiodras S, Nikolakopoulos I . Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill. 2009; 14(49). View

14.

Gates B . Responding to Covid-19 - A Once-in-a-Century Pandemic?. N Engl J Med. 2020; 382(18):1677-1679. DOI: 10.1056/NEJMp2003762. View

15.

Maurer J, Harris K, Parker A, Lurie N . Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. Vaccine. 2009; 27(42):5732-4. PMC: 2771376. DOI: 10.1016/j.vaccine.2009.07.080. View

16.

Wang Q, Yue N, Zheng M, Wang D, Duan C, Yu X . Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. Vaccine. 2018; 36(48):7262-7269. DOI: 10.1016/j.vaccine.2018.10.045. View

17.

Larson H, Jarrett C, Eckersberger E, Smith D, Paterson P . Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014; 32(19):2150-9. DOI: 10.1016/j.vaccine.2014.01.081. View

18.

Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J . Attitudes to vaccination: a critical review. Soc Sci Med. 2014; 112:1-11. DOI: 10.1016/j.socscimed.2014.04.018. View

19.

Larson H, Cooper L, Eskola J, Katz S, Ratzan S . Addressing the vaccine confidence gap. Lancet. 2011; 378(9790):526-35. DOI: 10.1016/S0140-6736(11)60678-8. View

20.

Maurer J, Uscher-Pines L, Harris K . Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?. Prev Med. 2010; 51(2):185-7. DOI: 10.1016/j.ypmed.2010.05.008. View